A decentralised care and the provision of free direct-acting antiviral agents (DAAs) can produce high rates of cure among people with hepatitis C virus (HCV) infection, according to a large-scale study conducted in India.The research, presented at The International Liver Congress in Paris, France, validated the efficacy and safety of generic all-oral DAA regimens delivered using a decentralised algorithm-based public health model. "We have shown in our study that it is possible to cure more than 90 percent of individuals with HCV infection in a highly dispersed population using well-trained teams in government medical colleges and district hospitals, and widely available DAAs," said Professor from the Postgraduate Institute of Medical Education and Research in Chandigarh.
"We believe the Punjab Model could be applied to many different populations with the aim of eliminating HCV," Dhiman…
